SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Apr 09
 -0.09 / -0.18%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

No recent news for SPDR® S&P Pharmaceuticals ETF.


1 month-6.84% 3 years+6.78%
3 months-8.03% 5 years+2.92%
1 year+28.67% Since inception+9.94%
Data through 04/10/2021

Quote Details

Previous close$49.14
Open day’s range48.69 – 49.05
Net asset value (NAV)49.04 (04/09/2021)
Daily volume65,710
Average volume (3 months)56,441
Data as of 3:59pm ET, 04/09/2021

Peer Comparisonvs. Health ETFs

Performance 5-yr return+2.92%+15.28%
Expense Gross exp ratio0.35%1.02%
Risk 5 year sharpe ratio0.290.80
Net assets$266.4M$2.3B
Average market cap$10.5B$31.9B
Average P/E24.427.0
Dividend / Share--0.29%


IEHS iShares Evolved U.S. Healthcare Staples ...
VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BMY Bristol-Myers Squibb4.39%
PFE Pfizer4.37%
MRK Merck4.36%
ZTS Zoetis Inc4.35%
JNJ Johnson & Johnson4.34%
HZNP Horizon Therapeutics PLC4.23%
CTLT Catalent Inc4.20%
PRGO Perrigo Company PLC4.16%
JAZZ Jazz Pharmaceuticals PLC4.14%
VTRS Viatris Inc4.10%